1. Chang S, Lim JH, Choi D, et al. Hepatic visceral larva migrans of Toxocara canis: CT and sonographic findings. AJR Am J Roentgenol. 2006; 187:W622–629.
2. Beaver PC, Jung RC, Cupp EW. Clinical parasitology. 9th ed.Philadelphia: Lea & Febiger;1984. p. 320–329.
3. Kaplan KJ, Goodman ZD, Ishak KG. Eosinophilic granuloma of the liver: a characteristic lesion with relationship to visceral larva migrans. Am J Surg Pathol. 2001; 25:1316–1321.
4. Beaver PC. The nature of visceral larva migrans. J Parasitol. 1969; 55:3–12.
Article
5. Kwon NH, Oh MJ, Lee SP, Lee BJ, Choi DC. The prevalence and diagnostic value of toxocariasis in unknown eosinophilia. Ann Hematol. 2006; 85:233–238.
Article
6. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003; 16:265–272.
Article
7. Jacquier P, Gottstein B, Stingelin Y, Eckert J. Immunodiagnosis of toxocarosis in humans: evaluation of a new enzyme-linked im-munosorbent assay kit. J Clin Microbiol. 1991; 29:1831–1835.
Article
8. Magnaval JF. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology. 1995; 110:529–533.
Article